Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Pulmonary Circulation
|
November 16, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)
Vallerie V McLaughlin, Richard Channick, Nick H Kim, et al.
Critical Care Medicine
|
October 1, 2019
Ramelteon for Prevention of Postoperative Delirium: A Randomized Controlled Trial in Patients Undergoing Elective Pulmonary Thromboendarterectomy
Stuti J Jaiswal, Anuja D Vyas, Andrew J Heisel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 6, 2023
Distal vessel pulmonary thromboendarterectomy: Results from a single institution
Timothy M Fernandes, Nick H Kim, Kim M Kerr, et al.
The Lancet. Respiratory Medicine
|
September 19, 2017
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Hossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
December 16, 2022
Multidisciplinary Approach to Chronic Thromboembolic Pulmonary Hypertension: Role of Radiologists
Lewis D Hahn, Demosthenes G Papamatheakis, Timothy M Fernandes, et al.
The Lancet. Respiratory Medicine
|
March 28, 2024
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Hossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
Pulmonary Circulation
|
June 12, 2015
Prevalence of coronary artery-pulmonary artery collaterals in patients with chronic thromboembolic pulmonary hypertension
Noel S Lee, Daniel G Blanchard, Kirk U Knowlton, et al.
American Heart Journal
|
January 21, 2014
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study
Kelly M Chin, David B Badesch, Ivan M Robbins, et al.
Annals of the American Thoracic Society
|
August 5, 2015
Efficacy of a Low-Tidal Volume Ventilation Strategy to Prevent Reperfusion Lung Injury after Pulmonary Thromboendarterectomy
Dina M Bates, Timothy M Fernandes, Beau V Duwe, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 26, 2025
Results of the MACiTEPH study of macitentan for the treatment of inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension
David P Jenkins, Sofija Cerovic, Dénes Csonka, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Pulmonary Circulation
|
November 16, 2022
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)
Vallerie V McLaughlin, Richard Channick, Nick H Kim, et al.
Critical Care Medicine
|
October 1, 2019
Ramelteon for Prevention of Postoperative Delirium: A Randomized Controlled Trial in Patients Undergoing Elective Pulmonary Thromboendarterectomy
Stuti J Jaiswal, Anuja D Vyas, Andrew J Heisel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 6, 2023
Distal vessel pulmonary thromboendarterectomy: Results from a single institution
Timothy M Fernandes, Nick H Kim, Kim M Kerr, et al.
The Lancet. Respiratory Medicine
|
September 19, 2017
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Hossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
December 16, 2022
Multidisciplinary Approach to Chronic Thromboembolic Pulmonary Hypertension: Role of Radiologists
Lewis D Hahn, Demosthenes G Papamatheakis, Timothy M Fernandes, et al.
The Lancet. Respiratory Medicine
|
March 28, 2024
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Hossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, et al.
Pulmonary Circulation
|
June 12, 2015
Prevalence of coronary artery-pulmonary artery collaterals in patients with chronic thromboembolic pulmonary hypertension
Noel S Lee, Daniel G Blanchard, Kirk U Knowlton, et al.
American Heart Journal
|
January 21, 2014
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study
Kelly M Chin, David B Badesch, Ivan M Robbins, et al.
Annals of the American Thoracic Society
|
August 5, 2015
Efficacy of a Low-Tidal Volume Ventilation Strategy to Prevent Reperfusion Lung Injury after Pulmonary Thromboendarterectomy
Dina M Bates, Timothy M Fernandes, Beau V Duwe, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 26, 2025
Results of the MACiTEPH study of macitentan for the treatment of inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension
David P Jenkins, Sofija Cerovic, Dénes Csonka, et al.
Page
of 12